Related Experiment Video
Updated: Sep 28, 2025

09:54
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
8.3K
Development of an mRNA replacement therapy for phenylketonuria
Carlos G Perez-Garcia1, Ramon Diaz-Trelles1, Jerel Boyd Vega1
1Arcturus Therapeutics, Inc., 10628 Science Center Drive, Suite 250, San Diego, CA 92121, USA.
Molecular Therapy. Nucleic Acids
|March 31, 2022
Summary
Phenylketonuria (PKU) is a metabolic disorder. mRNA therapy delivering human PAH protein successfully restored phenylalanine metabolism in a PKU mouse model, offering a potential new treatment.
Area of Science:
- Biochemistry
- Genetics
- Therapeutics
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder.
- It results from phenylalanine hydroxylase (PAH) gene mutations, leading to toxic phenylalanine accumulation and intellectual disability.
- Current treatments are limited.
Purpose of the Study:
- To investigate mRNA replacement therapy for PKU.
- To evaluate the efficacy of lipid nanoparticle-delivered mRNA encoding human PAH (hPAH) in a mouse model.
Main Methods:
- Developed LUNAR lipid nanoparticles encapsulating hPAH mRNA.
- Administered LUNAR-hPAH via intravenous infusion to Pah(enu2) mice.
- Assessed hPAH protein expression and Phe metabolism restoration.
Main Results:
- Successful delivery of hPAH mRNA to hepatocytes.
- High levels of hPAH protein expression observed.
- Restoration of phenylalanine metabolism in the treated mouse model.
- Normalization of hyperphenylalanemia and hypotyrosinemia.
Conclusions:
- mRNA replacement therapy is a viable strategy for PKU.
- LUNAR-hPAH demonstrated proof of principle in a PKU mouse model.
- This approach holds promise for treating PKU and similar genetic disorders.
Related Concept Videos
Inborn Errors of Metabolism
292
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
292
Translation
16.0K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
16.0K
Gene Therapy
26.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.0K
Nonsense-mediated mRNA Decay
10.9K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.9K
Alternative RNA Splicing
21.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.8K
In-vitro Mutagenesis
14.6K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.6K

